| |
Ophthalmology Innovation Summit (OIS)
The Ophthalmology Innovation Summit (OIS) will bring together leaders in the development of ophthalmic products, drugs, and devices. Meeting content will be presented and panel discussions delivered by noted experts in academia, industry, and healthcare investing.
The target audience includes: Clinical and pre-clinical researchers, Physicians/Clinicians, University technology transfer officers, Private and Public company executives, Corporate business development representatives, and Investors.
| Conference Co-Chairs |
Emmett T. Cunningham, Jr., MD, PhD, MPH
Partner
Clarus Ventures, LLC
William Link, PhD
Managing Director
Versant Ventures |
|
| Advisory Board Members |
Anthony Adamis, MD
Adjunct Professor of Ophthalmology & Visual Science
University of Illinois
Mark S. Blumenkranz, MD
Professor & Chairman
Department of Ophthalmology
Stanford University
Brook Byers
Partner
Kleiner Perkins Caufield & Byers
Eugene de Juan, Jr., MD
Founder & Vice Chairman
ForSight Labs, LLC
Lutz Giebel, PhD
Managing Partner
SV Life Sciences
David Guyer, MD
Partner
SV Life Sciences
|
Roman G. Rubio, MD
Acting Director, Ophthalmology,
Late Development
Genentech
Gilbert Kliman, MD
General Partner, Life Sciences
InterWest Partners
Angela Macfarlane
President & CEO
ForSight Labs, LLC
Samir Patel, MD
President & CEO
OphthoTech
Charles Warden
Managing Director
Versant Ventures
Scott M. Whitcup, MD
Executive Vice President, Research &
Development and
Chief Scientific Officer
Allergan |
To register, please contact Cathy Fenn, Registrar, at (516) 765-9005 ext. 210 or cathy@ibfconferences.com
For more information, speaking and sponsorship opportunities at this year’s conference, please contact Christina Riboldi: (516) 765-9005 ext. 180 or christina@ibfconferences.com
|
